Publicacións (19) Publicacións de Manuel Collado Rodríguez

filter_list Internal Medicine

2024

  1. Inhibition of lung tumorigenesis by transient reprogramming in cancer cells

    Cell Death and Disease, Vol. 15, Núm. 11

2023

  1. Epigenetic reprogramming of a distal developmental enhancer cluster drives SOX2 overexpression in breast and lung adenocarcinoma

    Nucleic acids research, Vol. 51, Núm. 19, pp. 10109-10131

2022

  1. SOX9 Triggers Different Epithelial to Mesenchymal Transition States to Promote Pancreatic Cancer Progression

    Cancers, Vol. 14, Núm. 4

2021

  1. RANK links senescence to stemness in the mammary epithelia, delaying tumor onset but increasing tumor aggressiveness

    Developmental Cell, Vol. 56, Núm. 12, pp. 1727-1741.e7

  2. The Jekyll and Hyde of Senescence in Cancer: TIMP1 Controls the Switch from Tumor-Controlling to Tumor-Promoting Senescence

    Cancer Cell, Vol. 39, Núm. 1, pp. 13-15

  3. Tumor microenvironment in metastatic colorectal cancer: The arbitrator in patients’ outcome

    Cancers, Vol. 13, Núm. 5, pp. 1-29

2020

  1. Senotherapy of Cancer

    SENOLYTICS IN DISEASE, AGEING AND LONGEVITY (SPRINGER INTERNATIONAL PUBLISHING AG), pp. 85-99

2019

  1. Context-Dependent Impact of RAS Oncogene Expression on Cellular Reprogramming to Pluripotency

    Stem Cell Reports, Vol. 12, Núm. 5, pp. 1099-1112

  2. Identification and characterization of Cardiac Glycosides as senolytic compounds

    Nature Communications, Vol. 10, Núm. 1

2018

  1. Susceptibility of Zebrafish to Vesicular Stomatitis Virus Infection

    Zebrafish, Vol. 15, Núm. 2, pp. 124-132

2014

  1. Tumour-infiltrating Gr-1 + myeloid cells antagonize senescence in cancer

    Nature, Vol. 515, Núm. 7525, pp. 134-137

2012

  1. Oncogenicity of the developmental transcription factor Sox9

    Cancer Research, Vol. 72, Núm. 5, pp. 1301-1315

2011

  1. Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence

    Cancer Cell, Vol. 19, Núm. 6, pp. 728-739

2010

  1. p19ARF Deficiency Reduces Macrophage and Vascular Smooth Muscle Cell Apoptosis and Aggravates Atherosclerosis

    Journal of the American College of Cardiology, Vol. 55, Núm. 20, pp. 2258-2268

2009

  1. Histone macroH2A isoforms predict the risk of lung cancer recurrence

    Oncogene, Vol. 28, Núm. 38, pp. 3423-3428

  2. WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway

    Cancer Research, Vol. 69, Núm. 24, pp. 9183-9191

2007

  1. Inactivation of the candidate tumor suppressor Par-4 in endometrial cancer

    Cancer Research, Vol. 67, Núm. 5, pp. 1927-1934

2004

  1. Different cooperating effect of p21 or p27 deficiency in combination with INK4a/ARF deletion in mice

    Oncogene, Vol. 23, Núm. 50, pp. 8231-8237

2001

  1. BCR-ABL-expressing cells transduced with the HSV-tk gene die by apoptosis upon treatment with ganciclovir

    Molecular Therapy, Vol. 3, Núm. 5, pp. 642-652